APA (7th ed.) Citation

Babu, S., Macklin, E. A., Jackson, K. E., Simpson, E., Mahoney, K., Yu, H., . . . Cudkowicz, M. E. (2020). Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 21(1/2), 15. https://doi.org/10.1080/21678421.2019.1672750

Chicago Style (17th ed.) Citation

Babu, Suma, et al. "Selection Design Phase II Trial of High Dosages of Tamoxifen and Creatine in Amyotrophic Lateral Sclerosis." Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 21, no. 1/2 (2020): 15. https://doi.org/10.1080/21678421.2019.1672750.

MLA (9th ed.) Citation

Babu, Suma, et al. "Selection Design Phase II Trial of High Dosages of Tamoxifen and Creatine in Amyotrophic Lateral Sclerosis." Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, vol. 21, no. 1/2, 2020, p. 15, https://doi.org/10.1080/21678421.2019.1672750.